Evidence map›Paper›PMID 24737736›Full record

ReviewExperimental biology and medicine (Maywood, N.J.)2014

Microphysiological modeling of the reproductive tract: a fertile endeavor.

Sharon L Eddie, J Julie Kim, Teresa K Woodruff, Joanna E Burdette

Abstract readReview
In one paragraph

Review in Experimental biology and medicine (Maywood, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Organoid technology in female reproductive biomedicine.Reproductive biology and endocrinology : RB&E · 2020
    Review
  6. Article
  7. Review
  8. Organs-On-Chip Models of the Female Reproductive System.Bioengineering (Basel, Switzerland) · 2019
    Review
  9. Review
  10. Microphysiologic systems in female reproductive biology.Experimental biology and medicine (Maywood, N.J.) · 2017
    Review
  11. Circadian hormone control in a human-on-a-chip: In vitro biology's ignored component?Experimental biology and medicine (Maywood, N.J.) · 2017
    Review
  12. Article
  13. Programming microphysiological systems for children's health protection.Experimental biology and medicine (Maywood, N.J.) · 2017
    Article
  14. Organs-on-chips: Progress, challenges, and future directions.Experimental biology and medicine (Maywood, N.J.) · 2017
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Biology coming full circle: joining the whole and the parts.Experimental biology and medicine (Maywood, N.J.) · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sharon L EddieDepartment of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, USA.
J Julie KimDepartment of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Teresa K WoodruffDepartment of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Joanna E BurdetteDepartment of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, USA joannab@uic.edu.

Funding

Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic SystemUH2ES022920 · NIEHS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOODRUFF, TERESA K · 2012 to 2013
$1.2M
NCATS NIH HHS UH2TR000498-01NIEHS NIH HHS UH2 ES022920
6 · The paper itself

Abstract

Preclinical toxicity testing in animal models is a cornerstone of the drug development process, yet it is often unable to predict adverse effects and tolerability issues in human subjects. Species-specific responses to investigational drugs have led researchers to utilize human tissues and cells to better estimate human toxicity. Unfortunately, human cell-derived models are imperfect because toxicity is assessed in isolation, removed from the normal physiologic microenvironment. Microphysiological modeling often referred to as 'organ-on-a-chip' or 'human-on-a-chip' places human tissue into a microfluidic system that mimics the complexity of human in vivo physiology, thereby allowing for toxicity testing on several cell types, tissues, and organs within a more biologically relevant environment. Here we describe important concepts when developing a repro-on-a-chip model. The development of female and male reproductive microfluidic systems is critical to sex-based in vitro toxicity and drug testing. This review addresses the biological and physiological aspects of the male and female reproductive systems in vivo and what should be considered when designing a microphysiological human-on-a-chip model. Additionally, interactions between the reproductive tract and other systems are explored, focusing on the impact of factors and hormones produced by the reproductive tract and disease pathophysiology.

Indexed as

Drug Evaluation, PreclinicalGenitalia, FemaleGenitalia, MaleLab-On-A-Chip DevicesModels, BiologicalTissue Culture TechniquesAnimalsFemaleHumansMaleMicrophysiological modelingreproductive signalingrepro-on-a-chip

Identifiers

PMID24737736
PMCPMC4156579

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.